Compare LSBK & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSBK | LFCR |
|---|---|---|
| Founded | 1891 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.6M | 143.9M |
| IPO Year | 2025 | 1996 |
| Metric | LSBK | LFCR |
|---|---|---|
| Price | $15.56 | $4.98 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 12.5K | ★ 171.5K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.27% | N/A |
| EPS Growth | ★ 49.23 | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.04 |
| P/E Ratio | $59.92 | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $11.50 | $3.63 |
| 52 Week High | $16.28 | $8.98 |
| Indicator | LSBK | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 42.20 | 55.30 |
| Support Level | $15.50 | $4.75 |
| Resistance Level | $15.68 | $5.45 |
| Average True Range (ATR) | 0.17 | 0.27 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 17.78 | 83.33 |
Lake Shore Bancorp Inc operates as a savings and loan holding company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit, and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.